|
Volumn 13, Issue 7, 2010, Pages 706-712
|
Clinical significance and diagnostic value of survivin autoantibody in non-small cell lung cancer patients
|
Author keywords
Anti survivin antibody; Combined detection; Indirect ELISA; Lung neoplasms; Prokaryotic expression
|
Indexed keywords
AUTOANTIBODY;
HYBRID PROTEIN;
SURVIVIN ANTIBODY;
TUMOR MARKER;
UNCLASSIFIED DRUG;
ADULT;
AFFINITY CHROMATOGRAPHY;
AGED;
ANTIBODY DETECTION;
ARTICLE;
DIAGNOSTIC VALUE;
DNA SEQUENCE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALE;
POLYACRYLAMIDE GEL ELECTROPHORESIS;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
WESTERN BLOTTING;
ADULT;
AGED;
AGED, 80 AND OVER;
AUTOANTIBODIES;
BLOTTING, WESTERN;
CARCINOMA, NON-SMALL-CELL LUNG;
CELL LINE, TUMOR;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMANS;
INHIBITOR OF APOPTOSIS PROTEINS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
RECOMBINANT PROTEINS;
SENSITIVITY AND SPECIFICITY;
TUMOR BURDEN;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 77957032541
PISSN: 10093419
EISSN: 19996187
Source Type: Journal
DOI: 10.3779/j.issn.1009-3419.2010.07.09 Document Type: Article |
Times cited : (8)
|
References (8)
|